{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T18:24:37Z","timestamp":1776450277500,"version":"3.51.2"},"reference-count":6,"publisher":"BMJ","license":[{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"DOI":"10.1136\/bmj.q102","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T11:30:12Z","timestamp":1706009412000},"page":"q102","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Artificial pancreases for type 1 diabetes: Better access is \u201cwatershed moment\u201d\u2014but delivery is key"],"prefix":"10.1136","author":[{"given":"Gareth","family":"Iacobucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,1,23]]},"reference":[{"key":"2024012303300672000_384.jan23_3.q102.1","unstructured":"National Institute for Health and Care Excellence. Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes. Technology appraisal guidance (TA943). Dec 2023. https:\/\/www.nice.org.uk\/guidance\/TA943"},{"key":"2024012303300672000_384.jan23_3.q102.2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.p2619"},{"key":"2024012303300672000_384.jan23_3.q102.3","unstructured":"Association of British Clinical Diabetologists. ABCD statement on pharmaceutical industry funding. https:\/\/abcd.care\/abcd-statement-pharmaceutical-industry-funding"},{"key":"2024012303300672000_384.jan23_3.q102.4","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-0635"},{"key":"2024012303300672000_384.jan23_3.q102.5","doi-asserted-by":"publisher","DOI":"10.1111\/dme.15015"},{"key":"2024012303300672000_384.jan23_3.q102.6","unstructured":"National Paediatric Diabetes Audit. Annual report 2021-22: Care processes and outcomes. Appendix 1: full audit analysis. https:\/\/www.rcpch.ac.uk\/sites\/default\/files\/2023-11\/npda_2021-22_apendix_1_extended_analysis.pdf"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.q102","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.q102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T11:30:15Z","timestamp":1706009415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.q102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,23]]},"references-count":6,"alternative-id":["10.1136\/bmj.q102"],"URL":"https:\/\/doi.org\/10.1136\/bmj.q102","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,23]]}}}